Ftse Mib
33.766,29
-0,06%
DAX
19.884,75
-0,57%
S&P 500
5.930,85
1,09%
NASDAQ
19.572,60
1,03%
Bitcoin
97.034,79
-0,18%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ ASLAN Pharmaceuticals Ltd (ASLN) ASLAN Pharmaceuticals Ltd (ASLN) Notizie

ASLN

ASLAN Pharmaceuticals (ASLN)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ASLN
DataOraFonteTitoloSimboloCompagnia
17/07/202413:29Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ASLNASLAN Pharmaceuticals Ltd
17/07/202413:25GlobeNewswire Inc.ASLAN Pharmaceuticals Announces it Has Filed for Voluntary Liquidation of Its Sole Operating Subsidiary and is Commencing Steps to Place Itself Into Voluntary LiquidationNASDAQ:ASLNASLAN Pharmaceuticals Ltd
12/06/202422:32Edgar (US Regulatory)Form F-3 - Registration statement by foreign private issuersNASDAQ:ASLNASLAN Pharmaceuticals Ltd
14/02/202422:45Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ASLNASLAN Pharmaceuticals Ltd
18/08/202313:33Edgar (US Regulatory)Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]NASDAQ:ASLNASLAN Pharmaceuticals Ltd
06/07/202314:09Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ASLNASLAN Pharmaceuticals Ltd
28/04/202313:29Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ASLNASLAN Pharmaceuticals Ltd
26/04/202323:27Edgar (US Regulatory)Securities Registration (ads, Immediate) (f-6ef)NASDAQ:ASLNASLAN Pharmaceuticals Ltd
26/04/202322:28Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:ASLNASLAN Pharmaceuticals Ltd
24/03/202312:33Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:ASLNASLAN Pharmaceuticals Ltd
20/03/202322:21Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ASLNASLAN Pharmaceuticals Ltd
03/03/202314:31Edgar (US Regulatory)Post-effective Amendment to a Previously Filed F-6. (f-6 Pos)NASDAQ:ASLNASLAN Pharmaceuticals Ltd
14/02/202322:02Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ASLNASLAN Pharmaceuticals Ltd
03/11/202221:08Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:ASLNASLAN Pharmaceuticals Ltd
31/10/202211:15TipRanksH.C. Wainwright Sticks to Their Buy Rating for Aslan Pharmaceuticals (ASLN)NASDAQ:ASLNASLAN Pharmaceuticals Ltd
15/09/202212:15TipRanksH.C. Wainwright Remains a Buy on Aslan Pharmaceuticals (ASLN)NASDAQ:ASLNASLAN Pharmaceuticals Ltd
13/09/202222:06Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:ASLNASLAN Pharmaceuticals Ltd
15/08/202212:25TipRanksH.C. Wainwright Keeps Their Buy Rating on Aslan Pharmaceuticals (ASLN)NASDAQ:ASLNASLAN Pharmaceuticals Ltd
23/05/202212:26TipRanksAslan Pharmaceuticals (ASLN) Receives a Buy from H.C. WainwrightNASDAQ:ASLNASLAN Pharmaceuticals Ltd
28/03/202212:26TipRanksH.C. Wainwright Reaffirms Their Buy Rating on Aslan Pharmaceuticals (ASLN)NASDAQ:ASLNASLAN Pharmaceuticals Ltd
25/03/202212:54Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:ASLNASLAN Pharmaceuticals Ltd
06/08/202113:46Edgar (US Regulatory)Amended Annual and Transition Report (foreign Private Issuer) (20-f/a)NASDAQ:ASLNASLAN Pharmaceuticals Ltd
25/05/202113:30GlobeNewswire Inc.ASLAN Pharmaceuticals to Participate In Fireside Chat at Jefferies Virtual Healthcare ConferenceNASDAQ:ASLNASLAN Pharmaceuticals Ltd
11/05/202113:30GlobeNewswire Inc.ASLAN Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Corporate UpdateNASDAQ:ASLNASLAN Pharmaceuticals Ltd
05/05/202111:22GlobeNewswire Inc.ASLAN Pharmaceuticals to Present Data on ASLAN004 at Society for Investigative DermatologyNASDAQ:ASLNASLAN Pharmaceuticals Ltd
22/04/202113:51GlobeNewswire Inc.ASLAN Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate UpdateNASDAQ:ASLNASLAN Pharmaceuticals Ltd
01/04/202112:13Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ASLNASLAN Pharmaceuticals Ltd
26/03/202121:19Edgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-3)NASDAQ:ASLNASLAN Pharmaceuticals Ltd
18/03/202112:27GlobeNewswire Inc.ASLAN Pharmaceuticals Appoints Dr Kathleen Metters as Independent DirectorNASDAQ:ASLNASLAN Pharmaceuticals Ltd
03/03/202106:42GlobeNewswire Inc.ASLAN Pharmaceuticals Announces Pricing of Public Offering of American Depositary SharesNASDAQ:ASLNASLAN Pharmaceuticals Ltd
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ASLN

La tua Cronologia

BIT
UCG
Unicredit
BIT
ISP
Intesa Sanpaolo
BIT
ENI
Eni
BIT
STLAM
Stellantis NV
BIT
SPM
Saipem
BIT
ENEL
Enel
BIT
TIT
Telecom Italia
BIT
RACE
Ferrari NV
BIT
STMMI
ST Microelectronics
BIT
BAMI
Banco BPM
BIT
BPE
Bper Banca
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
PRY
Prysmian
BIT
TEN
Tenaris
BIT
MONC
Moncler
BIT
FBK
Finecobank
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network